Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CRBG
CRBG logo

CRBG Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Corebridge Financial Inc (CRBG) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
23.860
1 Day change
4.97%
52 Week Range
36.570
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Corebridge Financial Inc (CRBG) is not a strong buy for a beginner, long-term investor at this moment. While the merger announcement with Equitable Holdings is a positive catalyst, the company's financial performance shows significant declines in net income and EPS. Additionally, hedge funds are heavily selling the stock, and technical indicators suggest a bearish trend. Given the lack of strong proprietary trading signals and mixed sentiment, holding off on a purchase is recommended for now.

Technical Analysis

The MACD is positive and expanding, indicating potential upward momentum. However, the RSI is neutral at 57.35, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 23.898, with resistance at 24.685 and support at 23.111. Overall, the technical indicators suggest a bearish trend.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
7
Buy
4

Positive Catalysts

  • The announcement of a $22 billion all-stock merger with Equitable Holdings, creating a unified company managing $1.5 trillion in assets, is a significant positive catalyst. This merger could enhance market positioning and operational scale.

Neutral/Negative Catalysts

  • Hedge funds are heavily selling the stock, with a 2778.97% increase in selling activity over the last quarter. Additionally, ongoing investigations into the merger by law firms like Rowley Law PLLC and Halper Sadeh LLC could create uncertainty and potential legal risks.

Financial Performance

In Q4 2025, revenue increased by 2.53% YoY to $6.77 billion. However, net income dropped significantly by -62.51% YoY to $814 million, and EPS fell by -57.89% YoY to 1.6. These declines indicate challenges in profitability despite modest revenue growth.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts maintain a generally positive outlook with multiple 'Outperform' and 'Overweight' ratings. However, most firms have lowered their price targets recently, with the average target now around $33. This reflects cautious optimism but also acknowledges challenges in the life insurance sector.

Wall Street analysts forecast CRBG stock price to rise
10 Analyst Rating
Wall Street analysts forecast CRBG stock price to rise
7 Buy
3 Hold
0 Sell
Moderate Buy
Current: 22.730
sliders
Low
33
Averages
37.3
High
40
Current: 22.730
sliders
Low
33
Averages
37.3
High
40
Keefe Bruyette
Outperform
initiated
$32
AI Analysis
2026-03-26
New
Reason
Keefe Bruyette
Price Target
$32
AI Analysis
2026-03-26
New
initiated
Outperform
Reason
Keefe Bruyette re-initiated coverage of Corebridge with an Outperform rating and $32 price target. The life insurance sector presents a mixed fundamental picture, and while companies have reduced liability tail risk, improved free cash flow conversion, and benefited from stronger growth, they face intensifying competition, rising investment leverage, greater balance sheet complexity, and eventual fading macro tailwinds, the analyst tells investors in a research note.
Barclays
Alex Scott
Overweight
downgrade
$34 -> $33
2026-03-11
Reason
Barclays
Alex Scott
Price Target
$34 -> $33
2026-03-11
downgrade
Overweight
Reason
Barclays analyst Alex Scott lowered the firm's price target on Corebridge to $33 from $34 and keeps an Overweight rating on the shares. The firm adjusted targets in the life insurance group after revisiting cash flow and private credit exposures to separate "perceived from actual risk."
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CRBG
Unlock Now

People Also Watch